Lulizol XL 1% Cream contains luliconazole 1% w/w, a topical imidazole antifungal agent indicated for the treatment of superficial dermatophytic infections such as tinea corporis, tinea cruris, and tinea pedis. Luliconazole exhibits broad-spectrum antifungal activity by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. The cream formulation allows for targeted delivery to affected skin areas, ensuring effective local concentrations with minimal systemic absorption. Lulizol XL 1% Cream is typically applied once daily to the affected area and surrounding skin for a duration determined by the severity and type of infection, usually ranging from one to four weeks. Clinical studies have demonstrated its efficacy and safety profile, with most patients experiencing symptom resolution and mycological cure. Common adverse effects are generally mild and may include localized irritation, erythema, or itching at the application site. The product is contraindicated in individuals with known hypersensitivity to luliconazole or any cream excipients. Lulizol XL 1% Cream should be used with caution in patients with extensive skin damage or secondary bacterial infections. It is important to complete the full course of therapy to prevent recurrence and resistance development.